Back to search results

ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Diffuse Midline Glioma (DMG) · Glioblastoma · Recurrent Ependymoma · Recurrent Malignant Central Nervous System Neoplasm · Spinal Cord Glioma · World Health Organization (WHO) Grade III Glioma · CNS Tumor · Central Nervous System Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of California, San Francisco, San Francisco, California, United States

    Contact: Study coordinator (PNOC Operations) · PNOC023@ucsf.edu · 415-502-1600
    Study coordinator · PNOC023@ucsf.edu
    Contact: Principal Investigator (Sabine Mueller, MD, PhD)

  • Children's National Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Lindsay Kilburn, MD) · lkilburn@childrensnational.org · 202-476-2800
    Contact: Principal Investigator (Lindsay Kilburn, MD)

  • Emory University, Atlanta, Georgia, United States

    Contact: Study coordinator (Tobey MacDonald, MD) · tobey.macdonald@emory.edu

  • University of Michigan, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Carl Koschmann, MD) · CCPBTC-CRA@med.umich.edu
    Contact: Study coordinator (Andrea Franson, MD)

  • Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Cassie Kline, MD) · klinec@chop.edu · 215-590-2299
    Contact: Principal Investigator (Cassie Kline, MD)

  • Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands

    Study coordinator · +31 88 972 7272
    Contact: Study coordinator (Evelien de Vos-Kerkhof) · e.kerkhof-5@prinsesmaximacentrum.nl
    Contact: Principal Investigator (Evelien de Vos-Kerkhof, MD)

  • The University Children's Hospital in Zurich, Zurich, Canton of Zurich, Switzerland

    Contact: Study coordinator (Nicolas Gerber, MD) · glioma@kispi.uzh.ch · +41 44 266 3117
    Contact: Study coordinator (Stephanie Matthes, PhD) · glioma@kispi.uzh.ch · +41 44 266 3726
Study leads

  • Sabine Mueller, MD, PhD

    Study Chair

    University of California, San Francisco

View source on ClinicalTrials.gov(opens in a new tab)